In short, no matter for either osteoclast or osteoblasts, CIH could cause the increase in expression of CB1R and further result in increase in the level of TRAP activation, which proves that CIH does cause ECS disorder and cause bone metabolic disorder through activating CB1 receptor in bone tissue. Here, ACP5 is linked to metabolic bone disorder.